Hematology NewsAML leads percent gains in 5-year survival among leukemiasJanuary 30, 2017CLLLeukemia, Myelodysplasia, TransplantationAMLALLCML
Hematology NewsLenalidomide maintenance extended progression-free survival in high-risk CLLJanuary 17, 2017CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsIbrutinib continues to wow in CLL/SLLJanuary 11, 2017CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsLenalidomide improves PFS after 1st and 2nd line CLL therapyDecember 14, 2016CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsIdelalisib held unlikely to become frontline therapy for CLLNovember 23, 2016CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsTargeted therapies predicted to blow out costs for CLLNovember 21, 2016CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsMinimal residual disease status predicts 10-year survival in CLLOctober 13, 2016CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsCD49d trumps novel recurrent mutations for predicting overall survival in CLLOctober 13, 2016CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsSurvival in CLL predicted by minimum residual diseaseAugust 29, 2016CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsCLL: Genetic aberrations predict poor treatment response in elderlyJuly 29, 2016CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsCAR T-cell therapy eyed for CLL patients with residual diseaseJuly 28, 2016CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsThree-drug regimen boosts progression-free survival in patients with relapsed CLL and adverse prognostic featuresJuly 13, 2016CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsAcalabrutinib shows efficacy as monotherapy in untreated CLLJune 23, 2016CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsIbrutinib at below standard dose may achieve good survival in CLLJune 22, 2016CLLLeukemia, Myelodysplasia, Transplantation
